System and method for locating detachment zone of a detachable implant

Information

  • Patent Grant
  • 10299755
  • Patent Number
    10,299,755
  • Date Filed
    Friday, December 18, 2015
    9 years ago
  • Date Issued
    Tuesday, May 28, 2019
    5 years ago
Abstract
A system and method for quickly detaching an implant and for locating the detachment zone of a detachable implant. A sensor determines a sudden change in the local environment as the sensor passes from within a microcatheter to being exposed to the vasculature. The sensor may be a temperature sensor, ultrasonic sensor, pressure sensor or the like. If the detachable implant assembly uses a heater coil to detach the implant, the heater coil may be used as a sensor. Additionally, the implant itself may be used as a sensor if a change in electrical resistance is detectable as the implant exits the microcatheter and changes shape.
Description
FIELD OF THE INVENTION

The present invention relates to systems and methods for delivering implant devices to a target site within the body of a patient. The present invention also relates to systems and methods for detecting a location of a detachment zone of a delivered implant device.


BACKGROUND OF THE INVENTION

Delivery of implantable therapeutic devices by less invasive means has been demonstrated to be desirable in numerous clinical situations. For example, vascular embolization has been used to control vascular bleeding, to occlude the blood supply to tumors, to occlude fallopian tubes, and to occlude vascular aneurysms, particularly intracranial aneurysms. In recent years, vascular embolization for the treatment of aneurysms has received much attention. As another example, the use of mesh or scaffold devices such as stents to open blocked vessels or to retain embolic coils have also received much attention.


Several different treatment modalities have been employed in the prior art for deploying implant devices. For example, numerous repositionable detachment systems for implant devices have been described in the prior art including U.S. Pat. No. 5,895,385 to Guglielmi et al. and U.S. Pat. No. 5,108,407 to Geremia et al., the contents of which are hereby incorporated by reference. Several systems, such as those disclosed in U.S. Pat. No. 6,500,149 to Gandhi et al. and U.S. Pat. No. 4,346,712 to Handa et al., the contents of which are hereby incorporated by reference, describe the use of a heater to detach and deploy the implant device.


Some percutaneously delivered detachable implant systems, such as those used to deliver occlusive coils to aneurysms, include a detachable implant that is temporarily attached to a pusher mechanism within a microcatheter. The pusher mechanism is used to advance the implant out of the distal end of the microcatheter. Once the implant has been advanced to a desired location relative to the microcatheter, referred to herein as a detachment zone, a detachment mechanism is employed to detach the implant from the pusher. It is important not to detach the implant prior to reaching the detachment zone as the implant may get hung up in the end of the catheter and subsequently get deployed at an undesirable location in the body.


Typically, in order to determine whether the implant has been advanced to the detachment zone relative to the microcatheter, radiopaque markers are used on both the microcatheter and either the pusher, the implant, or both. Thus, an operator uses the radiopaque markers to monitor the relative positions of the microcatheter and the implant as the implant is being advanced with the pusher. Monitoring the positions of the radiopaque markers requires the use of an x-ray device during the procedure. Using an x-ray imaging machine adds expense, complicates the procedure, and adds another space-consuming machine to the area surrounding the patient. Additionally, due to the coiled nature of the implant, the view of the radiopaque markers can become blocked by the coil.


SUMMARY OF THE INVENTION

The present invention is an implant delivery and detachment system used to position and deploy implantable devices such as coils, stents, filters, and the like within a body cavity including, but not limited to, blood vessels, fallopian tubes, malformations such as fistula and aneurysms, heart defects (e.g. left atrial appendages and sepal openings), and other luminal organs.


The system comprises an implant, a delivery catheter (generically referred to as the pusher or delivery pusher), a detachable joint for coupling the implant to the pusher, a heat generating apparatus (generically referred to as the heater), and a power source to apply energy to the heater.


In one aspect of the present invention, the implant is coupled to the pusher using a tether, string, thread, wire, filament, fiber, or the like. Generically this is referred to as the tether. The tether may be in the form of a monofilament, rod, ribbon, hollow tube, or the like. Many materials can be used to detachably join the implant to the pusher. One class of materials are polymers such as polyolefin, polyolefin elastomer such as those made by Dow marketed under the trade name Engage or Exxon marketed under the trade name Affinity, polyethylene, polyester (PET), polyamide (Nylon), polyurethane, polypropylene, block copolymer such as PEBAX or Hytrel, and ethylene vinyl alcohol (EVA); or rubbery materials such as silicone, latex, and Kraton. In some cases, the polymer may also be cross-linked with radiation to manipulate its tensile strength and melt temperature. Another class of materials is metals such as nickel titanium alloy (Nitinol), gold, and steel. The selection of the material depends on the capacity of the material to store potential energy, the melting or softening temperature, the power used for detachment, and the body treatment site. The tether may be joined to the implant and/or the pusher by welding, knot tying, soldering, adhesive bonding, or other means known in the art. In one embodiment where the implant is a coil, the tether may run through the inside lumen of the coil and be attached to the distal end of the coil. This design not only joins the implant to the pusher, but also imparts stretch resistance to the coil without the use of a secondary stretch resistant member. In other embodiments where the implant is a coil, stent, or filter; the tether is attached to the proximal end of the implant.


In another aspect of the present invention, the tether detachably coupling the implant to the pusher acts as a reservoir of stored (i.e. potential) energy that is released during detachment. This advantageously lowers the time and energy required to detach the implant because it allows the tether to be severed by application of heat without necessarily fully melting the material. The stored energy also may exert a force on the implant that pushes it away from the delivery catheter. This separation tends to make the system more reliable because it may prevent the tether from re-solidifying and holding the implant after detachment. Stored energy may be imparted in several ways. In one embodiment, a spring is disposed between the implant and pusher. The spring is compressed when the implant is attached to the pusher by joining one end of the tether to one of either the pusher or implant, pulling the free end of the tether until the spring is at least partially compressed, then affixing the free end of the tether to the other of the implant or the pusher. Since both ends of the tether are restrained, potential energy in the form of tension on the tether (or compression in the spring) is stored within the system. In another embodiment, one end of the tether is fixed as in the previous embodiment, and then the tether is placed in tension by pulling on the free end of the tether with a pre-determined force or displacement. When the free end of the tether is then affixed, the elongation (i.e. elastic deformation) of the tether material itself stores energy.


In another aspect of the present invention, a heater is disposed on or within the pusher, typically, but not necessarily, near the distal end of the pusher. The heater may be attached to the pusher by, for example, soldering, welding, adhesive bonding, mechanical boding, or other techniques known in the art. The heater may be in the form of a wound coil, heat pipe, hollow tube, band, hypotube, solid bar, toroid, or similar shape. The heater may be made from a variety of materials such as steel, chromium cobalt alloy, platinum, silver, gold, tantalum, tungsten, mangalin, chromium nickel alloy available from California Fine Wire Company under the trade name Stable Ohm, conductive polymer, or the like. The tether is disposed in proximity to the heater. The tether may pass through the lumen of a hollow or coil-type heater or may be wrapped around the heater. Although the tether may be disposed in direct contact with the heater, this is not necessary. For ease of assembly, the tether may be disposed be in proximity to, but not actually touching, the heater.


The delivery catheter or pusher is an elongate member with distal and proximal ends adapted to allow the implant to be maneuvered to the treatment site. The pusher comprises a core mandrel and one or more electrical leads to supply power to the heater. The pusher may taper in dimension and/or stiffness along the length, with the distal end usually being more flexible than the proximal end. In one embodiment, the pusher is adapted to be telescopically disposed within a delivery conduit such as a guide catheter or microcatheter. In another embodiment, the pusher contains an inner lumen allowing it to be maneuvered over a guide wire. In still another embodiment, the pusher can be maneuvered directly to the treatment site without a secondary device. The pusher may have a radiopaque marking system visible with fluoroscopy that allows it to be used in conjunction with radiopaque markings on the microcatheter or other adjunctive devices.


In another aspect of the present invention, the core mandrel is in the form of a solid or hollow shaft, wire, tube, hypotube, coil, ribbon, or combination thereof. The core mandrel may be made from plastic materials such as PEEK, acrylic, polyamide, polyimide, Teflon, acrylic, polyester, block copolymer such as PEBAX, or the like. The plastic member(s) may be selectively stiffened along the length with reinforcing fibers or wires made from metal, glass, carbon fiber, braid, coils, or the like. Alternatively, or in combination with plastic components, metallic materials such as stainless steel, tungsten, chromium cobalt alloy, silver, copper, gold, platinum, titanium, nickel titanium alloy (Nitinol), and the like may be used to form the core mandrel. Alternatively, or in combination with plastic and/or metallic components, ceramic components such as glass, optical fiber, zirconium, or the like may be used to form the core mandrel. The core mandrel may also be a composite of materials. In one embodiment, the core mandrel comprises an inner core of radiopaque material such as platinum or tantalum and an outer covering of kink-resistant material such as steel or chromium cobalt. By selectively varying the thickness of the inner core, radiopaque identifiers can be provided on the pusher without using secondary markers. In another embodiment, a core material, for example stainless steel, with desirable material properties such as kink resistance and/or compressive strength is selectively covered (by, for example, plating, drawing, or similar methods known in the art) with a low electrical resistance material such as copper, aluminum, gold, or silver to enhance its electrical conductivity, thus allowing the core mandrel to be used as an electrical conductor. In another embodiment, a core material, for example, glass or optical fiber, with desirable properties such as compatibility with Magnetic Resonance Imaging (MRI), is covered with a plastic material such as PEBAX or polyimide to prevent the glass from fracturing or kinking.


In another aspect of the present invention, the heater is attached to the pusher, and then one or more electrical conductors are attached to the heater. In one embodiment a two of conductive wires run substantially the length of the pusher and are coupled to the heater near the distal end of the pusher and to electrical connectors near the proximal end of the pusher. In another embodiment, one conductive wire runs the substantially the length of the pusher and the core mandrel itself is made from a conductive material or coated with a conductive material to act as a second electrical lead. The wire and the mandrel are coupled to the heater near the distal end and to one or more connectors near the proximal end of the pusher. In another embodiment, a bipolar conductor is coupled to the heater and is used in conjunction with radiofrequency (RF) energy to power the heater. In any of the embodiments, the conductor(s) may run in parallel to the core mandrel or may pass through the inner lumen of a substantially hollow core mandrel (for example, a hypotube).


In another aspect of the present invention, an electrical and/or thermally insulating cover or sleeve may be placed over the heater. The sleeve may be made from insulating materials such as polyester (PET), Teflon, block copolymer, silicone, polyimide, polyamide, and the like.


In another aspect of the present invention, electrical connector(s) are disposed near the proximal end of the pusher so that the heater can be electrically connected to a power source through the conductors. In one embodiment, the connectors are in the form of a plug with one or more male or female pins. In another embodiment, the connector(s) are tubes, pins, or foil that can be connected with clip-type connectors. In another embodiment, the connector(s) are tubes, pins, or foil that are adapted to mate with an external power supply.


In another aspect of the present invention, the pusher connects to an external power source so that the heater is electrically coupled to the power source. The power source may be from battery(s) or connected to the electrical grid by a wall outlet. The power source supplies current in the form of direct current (DC), alternating current (AC), modulated direct current, or radiofrequency (RF) at either high or low frequency. The power source may be a control box that operates outside of the sterile field or may be a hand-held device adapted to operate within a sterile field. The power source may be disposable, rechargeable, or may be reusable with disposable or rechargeable battery(s).


In another aspect of the present invention, the power source may comprise an electronic circuit that assists the user with detachment. In one embodiment, the circuit detects detachment of the implant and provides a signal to the user when detachment has occurred. In another embodiment, the circuit comprises a timer that provides a signal to the user when a pre-set length of time has elapsed. In another embodiment, the circuit monitors the number of detachments and provides a signal or performs an operation such as locking the system off when a pre-set number of detachments have been performed. In another embodiment, the circuit comprises a feedback loop that monitors the number of detachment attempts and increases the current, voltage, and/or detachment time in order to increase the likelihood of a successful detachment.


In another aspect of the present invention, the construction of the system allows for extremely short detachment time. In one embodiment the detachment time is less than 1 second.


In another aspect of the present invention, the construction of the system minimizes the surface temperature of the device during detachment. In one embodiment, the surface temperature at the heater during detachment is under 50° C. In another embodiment, the surface temperature at the heater during detachment is under 42° C.


The present invention is also a method and system for detecting the location of the detachment zone of a detachable coil as it exits the distal tip of the microcatheter without using radiopaque markers. Various sensing techniques are used to detect a change in various corresponding parameters due to the environmental difference between the inside of the microcatheter and exposure to a target site in the body.


In another aspect of the present invention a temperature sensor is utilized to detect a change in temperature as the sensor exits the microcatheter. The change in temperatures indicates that the detachable implant is in a desired detachment zone.


In another aspect of the present invention a pressure sensor is utilized to detect a change in pressure as the sensor exits the microcatheter. The change in pressure indicates that the detachable implant is in a desired detachment zone.


In another aspect of the present invention an ultrasound sensor is utilized to detect a change in environmental space as the sensor exits the microcatheter. When inside the microcatheter, the ultrasonic sensor detects the distance to the inner walls of the microcatheter. When outside the microcatheter, the ultrasonic sensor detects the increased distance to the inner walls of the vascular lumen or aneurysm. Hence, the change in distance indicates that the detachable implant is in a desired detachment zone.


Yet another aspect of the present invention the detachable coil is utilized as a detection mechanism. During navigation to the target site, the coil is contained, in a straight configuration, within the microcatheter. As the coil is pushed out of the microcatheter, it regains a curved configuration. If an electrical current is passed through the coil, the resistance to current flow through the coil changes as it curves. This change in resistance is used as a detection mechanism.


These and other aspects and features of the present invention will be appreciated upon consideration of the following drawings and detailed descriptions.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a cross-sectional side view of a first embodiment of a detachment system according to the present invention;



FIG. 2 illustrates a cross-sectional side view of a second embodiment of a detachment system according to the present invention;



FIG. 3A illustrates example direct signaling current according to the present invention;



FIG. 3B illustrates example alternating signaling current according to the present invention;



FIG. 4 illustrates a cross-sectional side view of a third embodiment of a detachment system according to the present invention;



FIG. 5 illustrates example temperature data of the surface of a detachment system as a function of time according to the present invention;



FIG. 6 illustrates a cross-sectional side view of an electrical connector of a detachment system according to the present invention;



FIG. 7 illustrates a cross-sectional side view of radiopaque layers of a detachment system according to the present invention; and



FIG. 8 illustrates a cross-sectional side view of a detachment system including a stent according to the present invention;



FIG. 9 illustrates a partially exploded perspective view of a delivery system according to the present invention;



FIG. 10 illustrates a cross-sectional side view of an electrical connector of a detachment system according to the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Turning to FIG. 1, a detachment system 100 of the present invention, and specifically the distal portion of the detachment system 100, is illustrated. The detachment system 100 includes a pusher 102 that is preferably flexible. The pusher 102 is configured for use in advancing an implant device 112 into and within the body of a patient and, specifically, into a target cavity site for implantation and delivery of the implant device 112. Potential target cavity sites include but are not limited to blood vessels and vascular sites, such as, e.g., aneurysms and fistula, heart openings and defects, such as, e.g., the left atrial appendage, and other luminal organs, such as, e.g., fallopian tubes.


A stretch-resistant tether 104 detachably couples the implant 112 to the pusher 102. In this example, the tether 104 is a plastic tube that is bonded to the pusher 102. A substantially solid cylinder could also be a design choice for the tether 104. The stretch resistant tether 104 extends at least partially through the interior lumen of an implant device 112.


Near the distal end of the pusher 102, a heater 106 is disposed in proximity to the stretch resistant tether 104. The heater 106 may be wrapped around the stretch resistant tether 104 such that the heater 106 is exposed to or otherwise in direct contact with the blood or the environment, or alternatively may be insulated by a sleeve, jacket, epoxy, adhesive, or the like. The pusher 102 comprises a pair of electrical wires, positive electrical wire 108 and negative electrical wire 110. The wires 108 and 110 are coupled to the heater 106 by any suitable means, such as, e.g., by welding or soldering.


The electrical wires 108, 110 are capable of being coupled to a source of electrical power (not shown). As illustrated the negative electrical wire 110 is coupled to the distal end of the heater 106 and the positive electrical wire 108 is coupled to the proximal end of the heater 106. In another embodiment, this configuration may be reversed, i.e., the negative electrical wire 110 is coupled to the proximal end of the heater 106 while the positive electrical wire 108 is coupled to the distal end of the heater 106.


Energy is applied to the heater 106 from the electrical wires 108, 110 in order to sever the portion of the tether 104 in the proximity of the heater 106. It is not necessary for the heater 106 to be in direct contact with the tether 104. The heater 106 merely should be in sufficient proximity to the tether 104 so that heat generated by the heater 106 causes the tether 104 to sever. As a result of activating the heater 106, the section of the stretch resistant tether 104 that is approximately distal from the heater 106 and within the lumen of an implant device 112 is released from the pusher 102 along with the implant device 112.


As illustrated, the implant device 112 is an embolic coil. An embolic coil suitable for use as the implant device 112 may comprise a suitable length of wire formed into a helical microcoil. The coil may be formed from a biocompatible material including platinum, rhodium, palladium, rhenium, tungsten, gold, silver, tantalum, and various alloys of these metals, as well as various surgical grade stainless steels. Specific materials include the platinum/tungsten alloy known as Platinum 479 (92% Pt, 8% W, available from Sigmund Cohn, of Mount Vernon, N.Y.) and nickel/titanium alloys (such as the nickel/titanium alloy known as Nitinol).


Another material that may be advantageous for forming the coil is a bimetallic wire comprising a highly elastic metal with a highly radiopaque metal. Such a bimetallic wire would also be resistant to permanent deformation. An example of such a bimetallic wire is a product comprising a Nitinol outer layer and an inner core of pure reference grade platinum, available from Sigmund Cohn, of Mount Vernon, N.Y., and Anomet Products, of Shrewsbury, Mass.


Commonly-assigned U.S. Pat. No. 6,605,101 provides a further description of embolic coils suitable for use as the implant device 112, including coils with primary and secondary configurations wherein the secondary configuration minimizes the degree of undesired compaction of the coil after deployment. The disclosure of U.S. Pat. No. 6,605,101 is fully incorporated herein by reference. Furthermore, the implant device 112 may optionally be coated or covered with a hydrogel or a bioactive coating known in the art.


The coil-type implant device 112 resists unwinding because the stretch resistant tether 104 that extends through the lumen of the implant device 112 requires substantially more force to plastically deform than the implant device 112 itself. The stretch resistant tether 104 therefore assists in preventing the implant device 112 from unwinding in situations in which the implant device 112 would otherwise unwind.


During assembly, potential energy may be stored within the device to facilitate detachment. In one embodiment, an optional spring 116 is placed between the heater 106 and the implant device 112. The spring is compressed during assembly and the distal end of the tether 104 may be tied or coupled to the distal end of the implant device 112, or may be melted or otherwise formed into an atraumatic distal end 114.


In one embodiment, the stretch resistant tether 104 is made from a material such as a polyolefin elastomer, polyethylene, or polypropylene. One end of the tether 104 is attached to the pusher 102 and the free end of the tether 104 is pulled through the implant 112 with the proximal end of the implant 112 flush to either the heater 106 (if no spring 116 is present) or to the compressed spring 116. A pre-set force or displacement is used to pre-tension the tether 104, thus storing energy in an axial orientation (i.e. co-linear or parallel to the long axis of the pusher 102) within the tether 104. The force or displacement depends on the tether material properties, the length of the tether 104 (which itself depends on the tether's attachment point on the pusher and the length of the implant). Generally, the force is below the elastic limit of the tether material, but sufficient to cause the tether to sever quickly when heat is applied. In one preferred embodiment wherein the implant to be deployed is a cerebral coil, the tether has a diameter within the range of approximately 0.001 to 0.007 inches. Of course the size of the tether can be changed to accommodate different types and sizes of other implants as necessary.


Turning to FIG. 2, another embodiment of a detachment system of the present invention, detachment system 200, is illustrated. Detachment system 200 shares several common elements with detachment system 100. For example, the same devices usable as the implant device 112 with detachment system 100 are also usable as the implant device 112 with detachment system 200. These include, e.g., various embolic microcoils and coils. The implant device 112 has been previously described with respect to detachment system 100. As with the implant device 112, the same identification numbers are used to identify other elements/components of detachment system 100 that may correspond to elements/components of detachment system 200. Reference is made to the description of these elements in the description of detachment system 100 as that description also applies to these common elements in detachment system 200.


With detachment system 200, an interior heating element 206 is used to separate a section of a stretch resistant tube 104 and an associated implant device 112 from the detachment system 200. Detachment system 200 includes a delivery pusher 202 that incorporates a core mandrel 218. The detachment system 200 further includes a positive electrical wire 208 and a negative electrical wire 210 that extend through the lumen of the delivery pusher 202.


To form the internal heating element 206, the positive electrical wire 208 and the negative electrical wire 210 may be coupled to the core mandrel 218 of the delivery pusher 202. Preferably, the electrical wires 208, 210 are coupled to a distal portion of the core mandrel 218.


In one embodiment, the positive electrical wire 208 is coupled to a first distal location on the core wire 218, and the negative electrical wire 210 is coupled to a second distal location on the core wire 218, with the second distal location being proximal to the first distal location. In another embodiment, the configuration is reversed, i.e., the positive electrical wire 208 is coupled to the second distal location and the negative electrical wire 210 is coupled to the first distal location on the core wire 218. When the positive electrical wire 208 and the negative electrical wire 210 are coupled to the distal portion of the core mandrel 218, the distal portion of the core mandrel 218 along with the electrical wires 208, 210 forms a circuit that is the interior heating element 206.


The heater 206 increases in temperature when a current is applied from a power source (not shown) that is coupled to the positive electrical wire 208 and the negative electrical wire 210. If a greater increase in temperature/higher degree of heat is required or desired, a relatively high resistance material such as platinum or tungsten may be coupled to the distal end of the core mandrel 218 to increase the resistance of the core mandrel 218. As a result, higher temperature increases are produced when a current is applied to the heater 206 than would be produced with a lower resistance material. The additional relatively high resistance material coupled to the distal end of the core mandrel 218 may take any suitable form, such as, e.g., a solid wire, a coil, or any other shape or material as described above.


Because the heater 206 is located within the lumen of the tube-shaped tether 104, the heater 206 is insulated from the body of the patient. As a result, the possibility of inadvertent damage to the surrounding body tissue due to the heating of the heater 206 may be reduced.


When a current is applied to the heater 206 formed by the core mandrel 218, the positive electrical wire 208, and the negative electrical wire 210, the heater 206 increases in temperature. As a result, the portion of the stretch resistant tether 104 in proximity to the heater 206 severs and is detached, along with the implant device 112 that is coupled to the tether 104, from the detachment system 200.


In one embodiment of the detachment system 200, the proximal end of the stretch resistant tether 104 (or the distal end of a larger tube (not shown) coupled to the proximal end of the stretch resistant tether 104) may be flared in order to address size constraints and facilitate the assembly of the detachment system 200.


In a similar manner as with detachment system 100, energy may be stored within the system with, for example, an optional compressive spring 116 or by pre-tensioning the tether 104 during assembly as previously described. When present, the release of potential energy stored in the system operates to apply additional pressure to separate the implant device 112, and the portion of the stretch resistant tether 104 to which the implant device 112 is coupled, away from the heater 206 when the implant device 112 is deployed. This advantageously lowers the required detachment time and temperature by causing the tether 104 to sever and break.


As with detachment system 100, the distal end of the stretch resistant tether 104 of detachment system 200 may be tied or coupled to the distal end of the implant device 112, or may be melted or otherwise formed into an atraumatic distal end 114.



FIG. 4 illustrates another preferred embodiment of a detachment system 300. In many respects, the detachment system 300 is similar to the detachment system 200 shown in FIG. 2 and detachment system 100 shown in FIG. 1. For example, the detachment system 300 includes a delivery pusher 301 containing a heater 306 that detaches an implant device 302. Detachment system 300 also utilizes a tether 310 to couple the implant device 302 to the delivery pusher 301.


In the cross-sectional view of FIG. 4, a distal end of the delivery pusher 301 is seen to have a coil-shaped heater 306 that is electrically coupled to electrical wires 308 and 309. These wires 308, 309 are disposed within the delivery pusher 301, exiting at a proximal end of the delivery pusher 301 and coupling to a power supply (not shown). The tether 310 is disposed in proximity to the heater 306, having a proximal end fixed within the delivery pusher 301 and a distal end coupled to the implant device 302. As current is applied through wires 308 and 309, the heater 306 increases in temperature until the tether 310 breaks, releasing the implant device 302.


To reduce the transfer of heat from the heater 306 to the surrounding tissue of the patient and to provide electrical insulation, an insulating cover 304 is included around at least the distal end of the outer surface of the delivery pusher 301. As the thickness of the cover 304 increases, the thermal insulating properties also increase. However, increased thickness also brings increased stiffness and a greater diameter to the delivery pusher 301 that could increase the difficulty of performing a delivery procedure. Thus, the cover 304 is designed with a thickness that provides sufficient thermal insulating properties without overly increasing its stiffness.


To enhance attachment of the tether 310 to the implant device 302, the implant device 302 may include a collar member 322 welded to the implant device 302 at weld 318 and sized to fit within the outer reinforced circumference 312 of the delivery pusher 301. The tether 310 ties around the proximal end of the implant device 302 to form knot 316. Further reinforcement is provided by an adhesive 314 that is disposed around the knot 316 to prevent untying or otherwise unwanted decoupling.


In a similar manner as with detachment systems 100 and 200, energy may be stored within the system with, for example, an optional compressive spring (similar to compressive spring 116 in FIG. 1 but not shown in FIG. 4) or by axially pre-tensioning the tether 104 during assembly. In this embodiment, one end of the tether 310 is attached near the proximal end of the implant device 302 as previously described. The free end of the tether 310 is threaded through a distal portion of the delivery pusher 301 until it reaches an exit point (not shown) of the delivery pusher 301. Tension is applied to the tether 310 in order to store energy in the form of elastic deformation within the tether material by, for example, placing a pre-determined force on the free end of the tether 310 or moving the taunt tether 310 a pre-determined displacement. The free end of the tether 310 is then joined to the delivery pusher 301 by, for example, tying a knot, applying adhesive, or similar methods known in the art.


When present, the release of potential energy stored in the system operates to apply additional pressure to separate the implant device 302, and the portion of the tether 310 to which the implant device 302 is coupled, away from the heater 306 when the implant device 302 is deployed. This advantageously lowers the required detachment time and temperature by causing the tether 310 to sever and break.


The present invention also provides for methods of using detachment systems such as detachment systems 100, 200, or 300. The following example relates to the use of detachment system 100, 200, or 300 for occluding cerebral aneurysms. It will, however, be appreciated that modifying the dimensions of the detachment system 100, 200, or 300 and the component parts thereof and/or modifying the implant device 112, 302 configuration will allow the detachment system 100, 200, or 300 to be used to treat a variety of other malformations within a body.


With this particular example, the delivery pusher 102, 202, or 301 of the detachment system 100, 200, or 300 may be approximately 0.010 inches to 0.030 inches in diameter. The tether 104, 310 that is coupled near the distal end of the delivery pusher 102, 202, or 301 and is coupled the implant device 112, 302 may be 0.0002 inches to 0.020 inches in diameter. The implant device 112, 302; which may be a coil, may be approximately 0.005 inches to 0.020 inches in diameter and may be wound from 0.0005 inch to 0.005 inch wire.


If potential energy is stored within the detachment system 100, 200, or 300, the force used to separate the implant 112, 302 from the pusher typically ranges up to 250 grams force.


The delivery pusher 102, 202, or 301 may comprise a core mandrel 218 and at least one electrically conductive wire 108, 110, 208, 210, 308, or 309. The core mandrel 218 may be used as an electrical conductor, or a pair of conductive wires may be used, or a bipolar wire may be used as previously described.


Although the detachment systems 100, 200, and 300 have been illustrated as delivering a coil, other implant devices are contemplated in the present invention. For example, FIG. 8 illustrates the detachment system 300 as previously described in FIG. 4 having an implant that is a stent 390. This stent 390 could similarly be detached by a similar method as previously described in regards to the detachment systems 100, 200, and 300. In a further example, the detachment systems 100, 200, or 300 may be used to deliver a filter, mesh, scaffolding or other medical implant suitable for delivery within a patient.



FIG. 7 presents an embodiment of a delivery pusher 350, which could be used in any of the embodiments as delivery pusher 102, 202, or 301, which includes radiopaque materials to communicate the position of the delivery pusher 350 to the user. Specifically, the radiopaque marker material is integrated into the delivery pusher 350 and varied in thickness at a desired location, facilitating easier and more precise manufacturing of the final delivery pusher 350.


Prior delivery pusher designs, such as those seen in U.S. Pat. No. 5,895,385 to Guglielmi, herein incorporated by reference, rely on high-density material such as gold, tantalum, tungsten, or platinum in the form of an annular band or coil. The radiopaque marker is then bonded to other, less dense materials, such as stainless steel, to differentiate the radiopaque section. Since the radiopaque marker is a separate element placed at a specified distance (often about 3 cm) from the tip of the delivery pusher, the placement must be exact or the distal tip of the delivery pusher 350 can result in damage to the aneurysm or other complications. For example, the delivery pusher 350 may be overextended from the microcatheter to puncture an aneurysm. Additionally, the manufacturing process to make a prior delivery pusher can be difficult and expensive, especially when bonding dissimilar materials.


The radiopaque system of the present invention overcomes these disadvantages by integrating a first radiopaque material into most of the delivery pusher 350 while varying the thickness of a second radiopaque material, thus eliminating the need to bond multiple sections together. As seen in FIG. 7, the delivery pusher 350 comprises a core mandrel 354 (i.e. the first radiopaque material), preferably made from radiopaque material such as tungsten, tantalum, platinum, or gold (as opposed to the mostly radiolucent materials of the prior art designs such as steel, Nitinol, and Elgiloy).


The delivery pusher 350 also includes a second, outer layer 352, having a different radiopaque level. Preferably, outer layer 352 is composed of a material having a lower radiopaque value than the core mandrel 354, such as Elgiloy, Nitinol, or stainless steel (commercially available from Fort Wayne Metals under the trade name DFT). In this respect, both the core mandrel 354 and the outer layer 352 are visible and distinguishable from each other under fluoroscopy. The outer layer 352 varies in thickness along the length of the delivery pusher 350 to provide increased flexibility and differentiation in radio-density. Thus the thicker regions of the outer layer 352 are more apparent to the user than the thinner regions under fluoroscopy.


The transitions in thickness of the outer layer 352 can be precisely created at desired locations with automated processes such as grinding, drawing, or forging. Such automated processes eliminate the need for hand measuring and placement of markers and further eliminates the need to bond a separate marker element to other radiolucent sections, thus reducing the manufacturing cost and complexity of the system.


In the present embodiment, the delivery pusher 350 includes three main indicator regions of the outer layer 352. A proximal region 356 is the longest of the three at 137 cm, while a middle region 358 is 10 cm and a distal region 360 is 3 cm. The length of each region can be determined based on the use of the delivery pusher 350. For example, the 3 cm distal region 360 may be used during a coil implant procedure, as known in the art, allowing the user to align the proximal edge of the distal region 360 with a radiopaque marker on the microcatheter within which the delivery pusher 350 is positioned. The diameter of each of the regions depends on the application and size of the implant. For a typical cerebral aneurysm application for example, the proximal region 356 may typically measure 0.005-0.015 inches, the middle region 358 may typically measure 0.001-0.008 inches, while the distal region 360 may typically measure 0.0005-0.010 inches. The core mandrel 354 will typically comprise between about 10-80% of the total diameter of the delivery pusher 350 at any point.


Alternately, the delivery pusher 350 may include any number of different regions greater than or less than the three shown in FIG. 7. Additionally, the radiopaque material of the core mandrel 354 may only extend partially through the delivery pusher 350. For example, the radiopaque material could extend from the proximal end of the core mandrel 354 to three centimeters from the distal end of the delivery pusher 350, providing yet another predetermined position marker visible under fluoroscopy.


In this respect, the regions 356, 358, and 360 of delivery pusher 350 provide a more precise radiopaque marking system that is easily manufactured, yet is readily apparent under fluoroscopy. Further, the increased precision of the markers may decrease complications relating to improper positioning of the delivery pusher during a procedure.


In operation, the microcatheter is positioned within a patient so that a distal end of the microcatheter is near a target area or lumen. The delivery pusher 350 is inserted into the proximal end of the microcatheter and the core mandrel 354 and outer layer 352 are viewed under fluoroscopy. The user aligns a radiopaque marker on the microcatheter with the beginning of the distal region 360, which communicates the location of the implant 112, 302 relative to the tip of the microcatheter.


In some situations, for example, small aneurysms where there may be an elevated risk of vessel damage from the stiffness of the delivery pusher 350, the user may position the proximal end of the implant slightly within the distal end of the microcatheter during detachment. The user then may push the proximal end of the implant 112, 302 out of the microcatheter with the next coil, an adjunctive device such as guidewire, or the delivery pusher 102, 202, 301, or 350. In another embodiment, the user may use the radiopaque marking system to locate the distal end of the delivery pusher outside the distal end of the microcatheter.


Once the implant device 112, 302 of the detachment system 100, 200, or 300 is placed in or around the target site, the operator may repeatedly reposition the implant device 112, 302 as necessary or desired.


When detachment of the implant device 112, 302 at the target site is desired, the operator applies energy to the heater 106, 206, or 306 by way of the electrical wires 108, 110, 208, 210, 308, or 309. The electrical power source for the energy may be any suitable source, such as, e.g., a wall outlet, a capacitor, a battery, and the like. For one aspect of this method, electricity with a potential of approximately 1 volt to 100 volts is used to generate a current of 1 milliamp to 5000 milliamps, depending on the resistance of the detachment system 100, 200, or 300.


One embodiment of a connector system 400 that can be used to electrically couple the detachment system 100, 200, or 300 to the power source is shown in FIG. 6. The connector system 400 includes an electrically conductive core mandrel 412 having a proximal end surrounded by an insulating layer 404. Preferably the insulating layer 404 is an insulating sleeve such as a plastic shrink tube of polyolefin, PET, Nylon, PEEK, Teflon, or polyimide. The insulating layer 404 may also be a coating such as polyurethane, silicone, Teflon, paralyene. An electrically conductive band 406 is disposed on top of the insulating layer 404 and secured in place by molding bands 414, adhesive, or epoxy. Thus, the core mandrel 412 and the conductive band 406 are electrically insulated from each other. The conductive band 406 is preferably composed of any electrically conductive material, such as silver, gold, platinum, steel, copper, conductive polymer, conductive adhesive, or similar materials, and can be a band, coil, or foil. Gold is especially preferred as the conductive material of the conductive band 406 because of the ability of gold to be drawn into a thin wall and its ready availability. The core mandrel 412 has been previously described and may be plated with, for example, gold, silver, copper, or aluminum to enhance its electrical conductivity.


The connector system 400 also includes two electrical wires 408 and 410 which connect to the conductive band 406 and core member 412, respectively, and to a heating element at the distal end of a delivery system such as those described in FIGS. 1, 2, and 4 (not shown in FIG. 6). These wires 408 and 410 are preferably connected by soldering, brazing, welding, laser bonding, or conductive adhesive, or similar techniques.


Once the user is ready to release the implant 112, 302 within the patient, a first electrical clip or connector from a power source is connected to a non-insulated section 402 of the core mandrel 412 and a second electrical clip or connector from the power source is connected to the conductive band 406. Electrical power is applied to the first and second electrical clips, forming an electrical circuit within the detachment system 100, 200, or 300, causing the heater 106, 206, or 306 to increase in temperature and sever the tether 104, 310.


Once the detachment system 100, 200, or 300 is connected to the power source the user may apply a voltage or current as previously described. This causes the heater 106, 206, or 306 to increase in temperature. When heated, the pre-tensioned tether 104, 310 will tend to recover to its unstressed (shorter) length due to heat-induced creep. In this respect, when the tether 104, 310 is heated by the heater 106, 206, or 306; its overall size shrinks. However, since each end of the tether 104, 310 is fixed in place as previously described, the tether 104, 310 is unable to shorten in length, ultimately breaking to release the implant device 112, 302.


Because there is tension already within the system in the form of a spring 116 or deformation of the tether material 104, 310; the amount of shrinkage required to break the tether 104, 310 is less than that of a system without a pre-tensioned tether. Thus, the temperature and time required to free the implant device 112, 302 is lower.



FIG. 5 is a graph showing the relationship between the temperature at the surface of PET cover 304 of the detachment system 300 and the time duration in which the heater coil 306 is activated. As can be seen, the surface temperature of the detachment system 300 during detachment does not vary linearly with time. Specifically, it takes just under 1 second for the heat generated by the heating coil 306 to penetrate the insulating cover 304. After 1 second, the surface temperature of the insulating cover 304 dramatically increases. Although different outer insulating material may slightly increase or decrease this 1-second surface temperature window, the necessarily small diameter of the detachment system 100, 200, or 300 prevents providing a thick insulating layer that may more significantly delay a surface temperature increase.


It should be understood that the embodiments of the detachment system 100, 200, or 300 include a variety of possible constructions. For example, the insulating cover 304 may be composed of Teflon, PET, polyamide, polyimide, silicone, polyurethane, PEEK, or materials with similar characteristics. In the embodiments 100, 200, or 300 the typical thickness of the insulating cover is 0.0001-0.040 inches. This thickness will tend to increase when the device is adapted for use in, for example, proximal malformations, and decrease when the device is adapted for use in more distal, tortuous locations such as, for example, cerebral aneurysms.


In order to minimize the damage and possible complications caused by such a surface temperature increase, the present invention detaches the implant device 112, 302 before the surface temperature begins to significantly increase. Preferably, the implant device 112, 302 is detached in less than a second, and more preferably, in less than 0.75 seconds. This prevents the surface temperature from exceeding 50° C. (122° F.), and more preferably, from exceeding 42° C. (107° F.).


Once the user attempts to detach the implant device 112, 302, it is often necessary to confirm that the detachment has been successful. The circuitry integrated into the power source may be used to determine whether or not the detachment has been successful. In one embodiment of the present invention an initial signaling current is provided prior to applying a detachment current (i.e. current to activate the heater 106, 206, or 306 to detach an implant 112, 302). The signaling current is used to determine the inductance in the system before the user attempts to detach the implant and therefore has a lower value than the detachment current, so as not to cause premature detachment. After an attempted detachment, a similar signaling current is used to determine a second inductance value that is compared to the initial inductance value. A substantial difference between the initial inductance and the second inductance value indicates that the implant 112, 302 has successfully been detached, while the absence of such a difference indicates unsuccessful detachment. In this respect, the user can easily determine if the implant 112, 302 has been detached, even for delivery systems that utilize nonconductive temperature sensitive polymers to attach an implant, such as those seen in FIGS. 1, 2, and 4.


In the following description and examples, the terms “current” and “electrical current” are used in the most general sense and are understood to encompass alternating current (AC), direct current (DC), and radiofreqeuncy current (RF) unless otherwise noted. The term “changing” is defined as any change in current with a frequency above zero, including both high frequency and low frequency. When a value is measured, calculated and/or saved, it is understood that this may be done either manually or by any known electronic method including, but not limited to, an electronic circuit, semiconductor, EPROM, computer chip, computer memory such as RAM, ROM, or flash; and the like. Finally, wire windings and toroid shapes carry a broad meaning and include a variety of geometries such as circular, elliptical, spherical, quadrilateral, triangular, and trapezoidal shapes.


When a changing current passes through such objects as wire windings or a toroid, it sets up a magnetic field. As the current increases or decreases, the magnetic field strength increase or decreases in the same way. This fluctuation of the magnetic field causes an effect known as inductance, which tends to oppose any further change in current. Inductance (L) in a coil wound around a core is dependant on the number of turns (N), the cross-sectional area of the core (A), the magnetic permeability of the core (μ), and length of the coil (l) according to equation 1 below:









L
=


0.4

π






N
2






A





μ

l





Equation





1.







The heater 106 or 306 is formed from a wound coil with proximal and distal electrically conductive wires 108, 110, 308, or 309 attached to a power source. The tether 104, 310 has a magnetic permeability μ1 and is positioned through the center of the resistive heater, having a length l, cross sectional area A, and N winds, forming a core as described in the previous equation. Prior to detachment, a changing signaling current i1, such as the waveforms shown in FIGS. 3A and 3B, with frequency f1, is sent through the coil windings. This signaling current is generally insufficient to detach the implant. Based on the signaling current, the inductive resistance XL (i.e. the electrical resistance due to the inductance within the system) is measured by an electronic circuit such as an ohmmeter. The initial inductance of the system L1 is then calculated according to the formula:










L
1

=


X
L


2

π






f
1







Equation





2.







This initial value of the inductance L1 depends on the magnetic permeability μ1 of the core of the tether 104, 310 according to Equation 1, and is saved for reference. When detachment is desired, a higher current and/or a current with a different frequency than the signaling current is applied through the resistive heater coil, causing the tether 104, 310 to release the implant 112, 302 as previously described. If detachment is successful, the tether 104, 310 will no longer be present within the heater 106, 306 and the inside of the heater 106, 306 will fill with another material such as the patient's blood, contrast media, saline solution, or air. This material now within the heater core will have a magnetic permeability μ2 that is different than the tether core magnetic permeability μ1.


A second signaling current and frequency f2 is sent through the heater 106, 306 and is preferably the same as the first signaling current and frequency, although one or both may be different without affecting the operation of the system. Based on the second signaling current, a second inductance L2 is calculated. If the detachment was successful, the second inductance L2 will be different (higher or lower) than the first inductance L1 due to the difference in the core magnetic permeabilities μ1 and μ2. If the detachment was unsuccessful, the inductance values should remain relatively similar (with some tolerance for measurement error). Once detachment has been confirmed by comparing the difference between the two inductances, an alarm or signal can be activated to communicate successful detachment to the user. For example, the alarm might include a beep or an indicator light.


Preferably, the delivery system 100, 300 used according to this invention connects to a device that automatically measures inductance at desired times, performs required calculations, and signals to the user when the implant device has detached from the delivery catheter. However, it should be understood that part or all of these steps can be manually performed to achieve the same result.


The inductance between the attached and detached states can also preferably be determined without directly calculating the inductance. For example, the inductive resistance XL can be measured and compared before and after detachment. In another example, the detachment can be determined by measuring and comparing the time constant of the system, which is the time required for the current to reach a predetermined percentage of its nominal value. Since the time constant depends on the inductance, a change in the time constant would similarly indicate a change in inductance.


The present invention may also include a feedback algorithm that is used in conjunction with the detachment detection described above. For example, the algorithm automatically increases the detachment voltage or current automatically after the prior attempt fails to detach the implant device. This cycle of measurement, attempted detachment, measurement, and increased detachment voltage/current continues until detachment is detected or a predetermined current or voltage limit is attained. In this respect, a low power detachment could be first attempted, followed automatically by increased power or time until detachment has occurred. Thus, battery life for a mechanism providing the detachment power is increased while the average coil detachment time is greatly reduced.


Referring now to FIGS. 9 and 10, there is shown an embodiment of an implant delivery system 500 of the present invention. The implant delivery system 500 and connector system 501 are generally similar to the delivery pusher 301 and connector system 400, respectively, previously described in this application and shown in FIGS. 4 and 6. However, the implant delivery system 500 preferably includes a sensor 502 for detecting when the implant device 302 has been advanced out of a microcatheter 506 to a desired detachment location.


Generally, detachment of the implant device 302 is preferred once the implant device 302 has fully exited the microcatheter 506. In this respect, the sensor 502 is positioned proximal to the implant device 302 on the pusher 301. The sensor 502 detects a change in its environment (i.e., from a location within the microcatheter 506 to a location outside the microcatheter 506, within vasculature of a patient) which is conveyed along wires 504 to the connector system 501 and ultimately to a human interface or display device (not shown) near the user. Preferably, the human interface may include a meter, electronic display, audible tone, or the like.


In yet another preferred embodiment not shown in the figures, the implant device 302 is utilized as a detection mechanism instead of or in addition to the sensor 502. During navigation of the pusher 500 to the target deployment site within the vasculature, the pusher 500 remains within the microcatheter 506 and the coil of the implant device 302 remains relatively straight, as it is confined by the walls defining the internal lumen of the microcatheter 506. When the implant assembly is deployed, the coil of the implant device 302 returns to a curved configuration. The relative resistance of the coil of the implant device 302 from its distal end to its proximal end changes as the coil changes from a straight to a coiled configuration. Thus, the change in resistance can be used as a location detection mechanism.


In one preferred embodiment, the sensor 502 may be a temperature sensor, detecting the temperature differential (e.g., a change from a normal or unbiased state) between the inside and outside of the microcatheter 506. Due to the relatively short period of time during which the microcatheter 506 is disposed within the vasculature, the internal temperature of the microcatheter 506 is typically cooler than the temperature of the vasculature. Hence, the temperature increases markedly as the sensor 502 reaches the detachment zone (i.e., a position of preferred detachment) just outside the microcatheter 506. This jump in temperature is thus used as an indication that the detachment zone has been reached during the advancement of the implant device 302.


In another preferred embodiment, the sensor 502 is a pressure sensor for detecting a pressure differential (e.g., a change from a normal or unbiased state) inside and outside of the microcatheter 506. The pressure inside the microcatheter 506 is relatively constant, whereas the pressure outside the microcatheter 506 varies with systole and diastole of the blood stream. Hence, the sudden change of pressure from a relatively static reading to a dynamic reading can be used as an indication that the implant device 302 has been advanced to the detachment zone.


In another preferred embodiment, the sensor 502 includes both an ultrasound transceiver and sensor for detecting an ultrasound differential (e.g., a change from a normal or unbiased state) between an inside and outside of the microcatheter 506. The ultrasonic transceiver sends ultrasonic waves and receives echoes of the waves in order to determine distances to objects surrounding the transceiver. The walls of the microcatheter are much closer to the transceiver than the walls of the vasculature. Hence, the sudden increase in distance measured by the transceiver can be used as an indication that the implant device 302 has been advanced to the desired detachment zone.


Other sensors capable of detecting differential characteristics between an inside and outside of a microcatheter 506 may also be used.


In another preferred embodiment, the heater coil 306 may serve as a sensor instead of or in addition to sensor 502. A resistance differential (e.g., a change from a normal or unbiased state) of the heater coil 306 may be measured as it is advanced through the microcatheter 506. As the heater coil 502 exits the microcatheter 506, the environment surrounding the heater coil changes from dry and relatively cool, to the warm blood filled environment of the vasculature. This change in environment affects the resistance of the heater coil 306 to a measurable degree. The following example is provided to show data obtained using the heater coil 306 as a sensor:


EXAMPLES

A series of experiments were conducted to determine the resistance change of heater coils as they are advanced through a microcatheter. The procedure used in order to obtain the data was as follows:


1. Obtain coil pusher


2. Prepare flow model.


3. Measure and record coil resistance on gold connector.


4. Advance coil pusher into microcatheter slightly beyond hub at proximal end.


5. Measure and record coil resistance. Mark data as 0% pusher length.


6. Advance coil pusher roughly 50% of entire length. Measure and record coil resistance. Mark data as 50% pusher length.


7. Repeat step 6 for 75% and 100% of pusher length, 100% being defined as the detachment zone exiting the distal end of the microcatheter.


8. Retract pusher and stop at above steps (75%, 50%, and 0%) and measure and record data.


9. Repeat cycle 3 times.


10. Measure and record coil pusher resistance one last time in air, outside of the microcatheter.


11. Detach implant and record results.


The following data were collected using various catheter types and heater coil materials. All resistance values shown in Tables 1-3 are in Ohms. Blank values indicate no data was obtained. Percent pusher length is defined as percentage of the pusher inserted into microcatheter, e.g. 100 percent equals detachment coil exited from distal end of microcatheter. Resistance was measured from gold connectors at proximal end of pusher.


As a result of this data, a conclusion was drawn that of the two heater coil materials tested, namely Stablohm and platinum, Stablohm had a coefficient of thermal resistivity that is much higher than that of the platinum. Other materials with a higher coefficient of thermal resistivity may be used to provide a higher sensitivity of the reading instrument. Moreover, the data show that there is a difference in the advancing coil resistance of approximately 0.5 ohm for the platinum coil and 0.4 ohm for the stablohm (from 75%-100% mark).


Example 1

The microcatheter used for Example 1 was a Rapid Transit microcatheter. The heater coil material used was Stablohm 710. The flow temperature was 99 degrees F. The heater coil resistance before testing was 42.1 Ohm. The heater coil resistance after the test was not recorded. Table 1 shows the results of Example 1.














TABLE 1







Percent Pusher
Advance
Advance
Retract



Length
Resistance 1
Resistance 2
Resistance 1





















0
42.1
42.1
42.1



50
42.2

42.2



75
42.5
42.5




100
42.6
42.6
42.6










Example 2

The microcatheter used for Example 2 was an Excelsior 1018 microcatheter. The heater coil material used was Platinum. The flow temperature was 98.7 degrees F. The heater coil resistance before testing was 40.9 Ohm, and the heater coil resistance after the test was 40.9 Ohm. Table 2 shows the results of Example 2.















TABLE 2





Percent








Pusher
Advance
Advance
Advance
Retract
Retract
Retract


Length
Resistance 1
Resistance 2
Resistance 3
Resistance 1
Resistance 2
Resistance 3





















0
40.8
41.0
41.0
41.0
41.0
41.0


50
40.9
41.2
41.1
41.1
41.1
41.1


75
41.2

41.3


41.2


100
41.7
41.6
41.6
41.7
41.6
41.6









Example 3

The microcatheter used for Example 3 was an Excelsior SL10 microcatheter. The heater coil material used was Platinum. The flow temperature was 98.6 degrees F. The heater coil resistance before testing was 40.8 Ohm, and the heater coil resistance after the test was 40.7 Ohm. Table 3 shows the results of Example 3.















TABLE 3





Percent








Pusher
Advance
Advance
Advance
Retract
Retract
Retract


Length
Resistance 1
Resistance 2
Resistance 3
Resistance 1
Resistance 2
Resistance 3





















0
40.8
40.9
40.8
40.9
40.8
40.7


50
41.0
41.0
41.0
41.0
40.9
41.0


75
41.1
41.2
41.2
41.2
41.1
41.2


100
41.6
41.6
41.7
41.6
41.6
41.7









Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.

Claims
  • 1. A method for determining when an implant has advanced out of a microcatheter, the method comprising the steps of: advancing an implant through a lumen of a microcatheter;obtaining with a sensor system resistance measurements from a resistance-type heater coil located in the microcatheter;prior to detachment of the implant from the pusher within the microcatheter, monitoring the resistance measurements for a change in resistance due to blood entering the microcatheter when the implant has advanced out of the microcatheter; andsignaling that the implant has advanced out of the microcatheter based on the change in resistance prior to detachment of the implant from the pusher.
  • 2. The method of claim 1, further comprising the step of communicating when the implant has advanced out of a microcatheter to a human interface device.
  • 3. The method of claim 1, wherein the sensor system is calibrated to determine a resistance change of the resistance-type heater coil when the heater coil has distally advance about 75% or more of a length of the microcatheter.
  • 4. A method of deploying an implant from a pusher, the method comprising the steps of: advancing an implant through a lumen of a microcatheter;obtaining with a sensor system resistance measurements from a resistance-type heater coil connected to the pusher and located in the microcatheter;prior to separation of the implant from the pusher, monitoring the resistance measurements for a change in resistance due to blood entering the microcatheter when the implant has advanced out of the microcatheter;signaling that the implant has advanced out of the microcatheter based on the change in resistance prior to separation of the implant from the pusher; andseparating the implant from the pusher based on said monitoring.
  • 5. The method of claim 4, wherein the step of separating the implant from the pusher based on said monitoring comprises breaking a tether coupling the implant to the pusher.
  • 6. The method of claim 4, wherein the sensor system is calibrated to determine a resistance change of the resistance-type heater coil when the heater coil has distally advance about 75% or more of a length of the microcatheter.
RELATED APPLICATIONS

The present application is a divisional of U.S. patent application Ser. No. 12/340,546 filed Dec. 19, 2008 entitled System And Method For Locating Detachment Zone Of A Detachable Implant, which claims priority from U.S. Provisional Application Ser. No. 61/016,154, filed Dec. 21, 2007 entitled System and Method for Locating Detachment Zone of a Detachable Implant, both of which are incorporated by reference herein in their entireties. This application also incorporates by reference U.S. Provisional Application Ser. No. 60/604,671, filed Aug. 25, 2004 entitled Thermal Detachment System For Implantable Devices; U.S. Provisional Application Ser. No. 60/685,342 filed May 27, 2005 entitled Thermal Detachment System For Implantable Devices; U.S. patent application Ser. No. 11/212,830 filed Aug. 25, 2005 entitled Thermal Detachment System For Implantable Devices; U.S. Provisional Application Ser. No. 61/016,180, filed Dec. 21, 2007 entitled Method of Detecting Implant Detachment.

US Referenced Citations (325)
Number Name Date Kind
4346712 Handa et al. Aug 1982 A
4364392 Strother et al. Dec 1982 A
4402319 Handa et al. Sep 1983 A
4512338 Balko et al. Apr 1985 A
4545367 Tucci Oct 1985 A
4551132 Pasztor et al. Nov 1985 A
4638803 Rand Jan 1987 A
RE32348 Pevsner Feb 1987 E
4735201 O'Reilly Apr 1988 A
4795741 Leshchiner et al. Jan 1989 A
4819637 Dormandy, Jr. et al. Apr 1989 A
4944746 Iwata et al. Jul 1990 A
4994069 Ritchart et al. Feb 1991 A
5001009 Whitbourne Mar 1991 A
5108407 Geremia et al. Apr 1992 A
5122136 Guglielmi et al. Jun 1992 A
5133731 Butler et al. Jul 1992 A
5147370 McNamara et al. Sep 1992 A
5163952 Froix Nov 1992 A
5167624 Butler et al. Dec 1992 A
5217484 Marks Jun 1993 A
5226911 Chee et al. Jul 1993 A
5250071 Palermo Oct 1993 A
5256146 Ensminger et al. Oct 1993 A
5258042 Mehta Nov 1993 A
5261916 Engelson Nov 1993 A
5269030 Pahno et al. Dec 1993 A
5304194 Chee et al. Apr 1994 A
5311027 Schuetz May 1994 A
5312415 Palermo May 1994 A
5331027 Whitbourne Jul 1994 A
5334201 Cowan Aug 1994 A
5334210 Gianturco Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5354295 Guglielmi et al. Oct 1994 A
5382259 Phelps et al. Jan 1995 A
5382260 Dormandy, Jr. et al. Jan 1995 A
5383887 Nadal Jun 1995 A
5423777 Tajiri et al. Jun 1995 A
5423829 Pham et al. Jun 1995 A
5423849 Engelson et al. Jun 1995 A
5443454 Tanabe et al. Aug 1995 A
5443478 Purdy Aug 1995 A
5443495 Buscemi et al. Aug 1995 A
5469867 Schmitt Nov 1995 A
5470338 Whitfield et al. Nov 1995 A
5476472 Dormandy Dec 1995 A
5498227 Mawad Mar 1996 A
5498250 Prather Mar 1996 A
5522836 Palermo Jun 1996 A
5525334 Ito et al. Jun 1996 A
5529653 Glastra Jun 1996 A
5540680 Guglielmi et al. Jun 1996 A
5536274 Neuss Jul 1996 A
5569245 Guglielmi et al. Oct 1996 A
5578074 Mirigian Nov 1996 A
5580568 Greff et al. Dec 1996 A
5582619 Ken Dec 1996 A
5593412 Martinez et al. Jan 1997 A
5601600 Ton Feb 1997 A
5609608 Benett et al. Mar 1997 A
5612050 Rowe et al. Mar 1997 A
5614204 Cochrum Mar 1997 A
5624449 Pham et al. Apr 1997 A
5624461 Mariant Apr 1997 A
5624685 Takahashi et al. Apr 1997 A
5634936 Linden et al. Jun 1997 A
5639277 Mariant et al. Jun 1997 A
5645558 Horton Jul 1997 A
5658308 Snyder Aug 1997 A
5667767 Greff et al. Sep 1997 A
5669931 Kupiecki et al. Sep 1997 A
5690667 Gia Nov 1997 A
5690671 McGurk et al. Nov 1997 A
5700258 Mirigian et al. Dec 1997 A
5702361 Evans et al. Dec 1997 A
5718711 Berenstein et al. Feb 1998 A
5722989 Fitch et al. Mar 1998 A
5725568 Hastings Mar 1998 A
5733329 Wallace et al. Mar 1998 A
5743905 Eder et al. Apr 1998 A
5749891 Ken et al. May 1998 A
5749894 Engelson May 1998 A
5749921 Lenker et al. May 1998 A
5750585 Park et al. May 1998 A
5759161 Ogawa et al. Jun 1998 A
5766204 Porter et al. Jun 1998 A
5766219 Horton Jun 1998 A
5792154 Doan et al. Aug 1998 A
5800454 Jacobsen et al. Sep 1998 A
5800455 Palermo et al. Sep 1998 A
5814062 Sepetka et al. Sep 1998 A
5823198 Jones et al. Oct 1998 A
5830178 Jones et al. Nov 1998 A
5830230 Berryman et al. Nov 1998 A
5846210 Ogawa et al. Dec 1998 A
5846247 Unsworth et al. Dec 1998 A
5851206 Guglielmi et al. Dec 1998 A
5851508 Greff et al. Dec 1998 A
5853418 Ken et al. Dec 1998 A
5891058 Taki et al. Apr 1999 A
5891130 Palermo et al. Apr 1999 A
5895385 Guglielmi et al. Apr 1999 A
5902254 Magram May 1999 A
5911737 Lee et al. Jun 1999 A
5925037 Guglielmi et al. Jul 1999 A
5925059 Palermo et al. Jul 1999 A
5925061 Ogi et al. Jul 1999 A
5941888 Wallace et al. Aug 1999 A
5944733 Engelson Aug 1999 A
5947963 Guglielmi Sep 1999 A
5964771 Beyar et al. Oct 1999 A
5964797 Ho Oct 1999 A
5976126 Guglielmi et al. Nov 1999 A
5976131 Guglielmi et al. Nov 1999 A
5984629 Brodersen et al. Nov 1999 A
6010498 Guglielmi Jan 2000 A
6013084 Ken et al. Jan 2000 A
6015424 Rosenbluth et al. Jan 2000 A
6033423 Ken et al. Mar 2000 A
6048338 Larson et al. Apr 2000 A
6053873 Govari et al. Apr 2000 A
6056759 Fiedler May 2000 A
6059815 Lee et al. May 2000 A
6063070 Eder May 2000 A
6063100 Diaz et al. May 2000 A
6066133 Guglielmi et al. May 2000 A
6068644 Lulo et al. May 2000 A
6083220 Guglielmi et al. Jul 2000 A
6086599 Lee et al. Jul 2000 A
6091980 Squire et al. Jul 2000 A
6102932 Kurz Aug 2000 A
6117142 Goodson et al. Sep 2000 A
6159206 Ogawa Dec 2000 A
6165178 Bashiri et al. Dec 2000 A
6193728 Ken et al. Feb 2001 B1
6221066 Ferrera et al. Apr 2001 B1
6224609 Ressemann et al. May 2001 B1
6238403 Greene, Jr. et al. May 2001 B1
6238415 Sepetka et al. May 2001 B1
6277126 Barry et al. Aug 2001 B1
6293960 Ken Sep 2001 B1
6296622 Kurz et al. Oct 2001 B1
6299619 Greene, Jr. et al. Oct 2001 B1
6319267 Kurz Nov 2001 B1
6338657 Harper et al. Jan 2002 B1
6361547 Hieshima Mar 2002 B1
6371979 Beyar et al. Apr 2002 B1
6375668 Gifford et al. Apr 2002 B1
6375669 Rosenbluth et al. Apr 2002 B1
6383204 Ferrera et al. May 2002 B1
6425893 Guglielmi Jul 2002 B1
6428557 Hilaire Aug 2002 B1
6440098 Luscher Aug 2002 B1
6447522 Gambale et al. Sep 2002 B2
6478773 Gandhi Nov 2002 B1
6494884 Gifford, III et al. Dec 2002 B2
6500149 Gandhi et al. Dec 2002 B2
6514264 Naglreiter Feb 2003 B1
6526979 Nikolchev et al. Mar 2003 B1
6544225 Lulo et al. Apr 2003 B1
6554849 Jones et al. Apr 2003 B1
6602261 Greene, Jr. et al. Aug 2003 B2
6602269 Wallace et al. Aug 2003 B2
6607538 Ferrera et al. Aug 2003 B1
6610046 Usami et al. Aug 2003 B1
6634361 Nikolchev et al. Oct 2003 B1
6645240 Yee Nov 2003 B2
6656173 Palermo Dec 2003 B1
6684884 Nikolchev et al. Feb 2004 B2
6689141 Ferrera et al. Feb 2004 B2
6705323 Nikolchev et al. Mar 2004 B1
6716238 Elliott Apr 2004 B2
6740073 Saville May 2004 B1
6743236 Barry et al. Jun 2004 B2
6743251 Eder Jun 2004 B1
6807446 Fenn et al. Oct 2004 B2
6849081 Sepetka et al. Feb 2005 B2
6849087 Chuter Feb 2005 B1
6855125 Shanley May 2005 B2
6905503 Gifford, III et al. Jun 2005 B2
6953465 Dieck et al. Oct 2005 B2
6953473 Porter Oct 2005 B2
6958068 Hieshima Oct 2005 B2
6964671 Cheng et al. Nov 2005 B2
6966892 Gandhi et al. Nov 2005 B2
6989020 Jones et al. Jan 2006 B2
7001422 Escamilla et al. Feb 2006 B2
7014645 Greene, Jr. et al. Mar 2006 B2
7048719 Monetti May 2006 B1
7063671 Couvillon, Jr. Jun 2006 B2
7063707 Bose et al. Jun 2006 B2
7066904 Rosenthal et al. Jun 2006 B2
7070609 West Jul 2006 B2
7108708 Cheng et al. Sep 2006 B2
7137990 Herbert et al. Nov 2006 B2
7147618 Kurz Dec 2006 B2
7166122 Aganon et al. Jan 2007 B2
7179276 Barry et al. Feb 2007 B2
7182774 Barry et al. Feb 2007 B2
7198613 Gandhi et al. Apr 2007 B2
7201768 Diaz et al. Apr 2007 B2
7208003 Davis et al. Apr 2007 B2
7238194 Monstdt et al. Jul 2007 B2
7255707 Ramzipoor et al. Aug 2007 B2
7264628 Jones et al. Sep 2007 B2
7270674 Jones et al. Sep 2007 B2
7309345 Wallace Dec 2007 B2
7323000 Monstdt et al. Jan 2008 B2
7344558 Lorenzo et al. Mar 2008 B2
7351254 Magers Apr 2008 B2
7357809 Jones et al. Apr 2008 B2
7367987 Balgobin et al. May 2008 B2
7371251 Mitelberg et al. May 2008 B2
7371252 Balgobin et al. May 2008 B2
7377932 Mitelberg et al. May 2008 B2
7513878 Hamilton Apr 2009 B2
7553321 Litzenberg et al. Jun 2009 B2
7575582 Gandhi et al. Aug 2009 B2
7578826 Gandhi et al. Aug 2009 B2
7582101 Jones et al. Sep 2009 B2
7591833 Jones et al. Sep 2009 B2
7608089 Wallace et al. Oct 2009 B2
7628797 Tieu et al. Dec 2009 B2
7651513 Teoh et al. Jan 2010 B2
7691118 Gorospe Apr 2010 B2
7708754 Balgobin et al. May 2010 B2
7708755 Davis, III et al. May 2010 B2
7740637 Gandhi et al. Jun 2010 B2
7771451 Ramzipoor Aug 2010 B2
7776054 Gandhi et al. Aug 2010 B2
7780680 Gandhi et al. Aug 2010 B2
7789891 Wallace Sep 2010 B2
20010029352 Gandhi et al. Oct 2001 A1
20020091380 Wheelock et al. Jul 2002 A1
20020107534 Schaefer et al. Aug 2002 A1
20020188341 Elliott Dec 2002 A1
20030023262 Welch Jan 2003 A1
20030045901 Opolski Mar 2003 A1
20030069539 Gandhi et al. Apr 2003 A1
20030125790 Fastovsky et al. Jul 2003 A1
20040002731 Aganon et al. Jan 2004 A1
20040002733 Teoh Jan 2004 A1
20040034363 Wilson et al. Feb 2004 A1
20040044385 Fenn et al. Mar 2004 A1
20040204701 Cox et al. Oct 2004 A1
20050021023 Guglielmi et al. Jan 2005 A1
20050043755 Wilson et al. Feb 2005 A1
20050118865 Henningsen Jun 2005 A1
20050131523 Bashiri et al. Jun 2005 A1
20050149108 Cox Jul 2005 A1
20050154417 Sepetka et al. Jul 2005 A1
20050171572 Martinez Aug 2005 A1
20050222580 Gifford, III et al. Oct 2005 A1
20050283182 Pierce et al. Dec 2005 A1
20060025801 Lulo et al. Feb 2006 A1
20060025803 Mitelberg et al. Feb 2006 A1
20060036280 French et al. Feb 2006 A1
20060052815 Fitz et al. Mar 2006 A1
20060079923 Chhabra et al. Apr 2006 A1
20060116708 Ogawa et al. Jun 2006 A1
20060135986 Wallace et al. Jun 2006 A1
20060173488 Takeuchi et al. Aug 2006 A1
20060184092 Atanasoska et al. Aug 2006 A1
20060200192 Fitz et al. Sep 2006 A1
20060241682 Kurz Oct 2006 A1
20060241684 Wilson et al. Oct 2006 A1
20060241685 Wilson et al. Oct 2006 A1
20060253023 Lewis et al. Nov 2006 A1
20060253149 Gandhi et al. Nov 2006 A1
20060271098 Peacock, III Nov 2006 A1
20060271099 Marks et al. Nov 2006 A1
20060276826 Mitelberg et al. Dec 2006 A1
20070055302 Henry et al. Mar 2007 A1
20070100419 Licata et al. May 2007 A1
20070104752 Lee et al. May 2007 A1
20070167911 Gandhi et al. Jul 2007 A1
20070185443 Euteneuer et al. Aug 2007 A1
20070185457 Euteneuer et al. Aug 2007 A1
20070191879 Gandhi et al. Aug 2007 A1
20070208276 Kornkven Volk et al. Sep 2007 A1
20070239141 Hartley et al. Oct 2007 A1
20070239193 Simon et al. Oct 2007 A1
20080103585 Monstadt et al. May 2008 A1
20080119887 Que et al. May 2008 A1
20080125855 Henkes et al. May 2008 A1
20080133028 Wilson et al. Jun 2008 A1
20080140111 Wilson et al. Jun 2008 A1
20080140178 Rasmussen et al. Jun 2008 A1
20080147201 Wilson et al. Jun 2008 A1
20080172119 Yamasaki et al. Jul 2008 A1
20080221554 O'Connor et al. Sep 2008 A1
20080283066 Delgado et al. Nov 2008 A1
20080287982 Harreld Nov 2008 A1
20090018653 Bashiri et al. Jan 2009 A1
20090054905 Levy Feb 2009 A1
20090062726 Ford et al. Mar 2009 A1
20090076540 Marks et al. Mar 2009 A1
20090099592 Buiser et al. Apr 2009 A1
20090138036 Nardone et al. May 2009 A1
20090143786 Bashiri et al. Jun 2009 A1
20090163780 Tieu Jun 2009 A1
20090163986 Tieu et al. Jun 2009 A1
20090177261 Teoh et al. Jul 2009 A1
20090270901 Kelleher et al. Oct 2009 A1
20090270903 Litzenberg et al. Oct 2009 A1
20090275971 Kelleher et al. Nov 2009 A1
20090299275 Gandhi et al. Dec 2009 A1
20090318892 Aboytes et al. Dec 2009 A1
20100004731 Gandhi et al. Jan 2010 A1
20100042133 Ramzipoor et al. Feb 2010 A1
20100069838 Weber et al. Mar 2010 A1
20100094395 Kellett Apr 2010 A1
20100106162 Jaeger et al. Apr 2010 A1
20100152650 Schrodt Jun 2010 A1
20100152828 Pakbaz et al. Jun 2010 A1
20100160944 Teoh et al. Jun 2010 A1
20100160953 Ngo et al. Jun 2010 A1
20100234872 Guo et al. Sep 2010 A1
20100249823 Gandhi et al. Sep 2010 A1
20100256666 Chen et al. Oct 2010 A1
20100268158 Porter Oct 2010 A1
20100268201 Tieu et al. Oct 2010 A1
20100268204 Tieu et al. Oct 2010 A1
20100268252 Chen et al. Oct 2010 A1
Foreign Referenced Citations (132)
Number Date Country
2005276980 Mar 2006 AU
2493016 Feb 2004 CA
101589972 Dec 2009 CN
20110506 May 2011 CN
0547530 Jun 1993 EP
0707830 Apr 1996 EP
0719522 Jul 1996 EP
0941703 Sep 1999 EP
0941704 Sep 1999 EP
0948935 Oct 1999 EP
0992220 Oct 1999 EP
1010396 Jun 2000 EP
1073377 Feb 2001 EP
0824010 Feb 2003 EP
1188413 Jul 2003 EP
0830873 Apr 2004 EP
1513461 Mar 2005 EP
1538997 Jun 2005 EP
1266629 Nov 2006 EP
1738698 Jan 2007 EP
1791590 Jun 2007 EP
1797832 Jun 2007 EP
1797833 Jun 2007 EP
1621150 Sep 2007 EP
1621148 Oct 2007 EP
1339328 Feb 2008 EP
1621149 Feb 2008 EP
1889577 Feb 2008 EP
1738694 Jul 2008 EP
1743600 Jul 2008 EP
1738696 Aug 2008 EP
1255492 Oct 2008 EP
1792576 Oct 2008 EP
1795133 Oct 2008 EP
1255493 Nov 2008 EP
1738693 Nov 2008 EP
1992308 Nov 2008 EP
1813196 Dec 2008 EP
1120088 Apr 2009 EP
1825823 Jun 2009 EP
1738697 Apr 2010 EP
1792575 Jun 2010 EP
2131754 Jun 2010 EP
2231030 Sep 2010 EP
2234562 Oct 2010 EP
1985240 Feb 2011 EP
1886632 Apr 2011 EP
2319455 May 2011 EP
1813213 Dec 2011 EP
2111828 Feb 2012 EP
52141092 Nov 1977 JP
56043962 Apr 1981 JP
01-238874 Sep 1989 JP
5158069 Jun 1992 JP
07-265431 Oct 1995 JP
H08506033 Jul 1996 JP
2008-250576 Apr 1998 JP
2003-521991 Jul 2003 JP
2005-524479 Aug 2005 JP
2008-510594 Apr 2008 JP
2011-507636 Mar 2011 JP
2011-507638 Mar 2011 JP
WO1991013592 Sep 1991 WO
WO1994006503 Mar 1994 WO
WO1994010936 May 1994 WO
WO1995007667 Mar 1995 WO
WO1995023558 Sep 1995 WO
WO1995027443 Oct 1995 WO
WO1996000034 Jan 1996 WO
WO1996000104 Jan 1996 WO
WO1997026939 Jul 1997 WO
WO1997027888 Aug 1997 WO
WO1998029042 Jul 1998 WO
WO1998037816 Sep 1998 WO
WO1998040033 Sep 1998 WO
WO1999002094 Jan 1999 WO
WO1999006097 Feb 1999 WO
WO1999009894 Mar 1999 WO
WO1999029260 Jun 1999 WO
WO1999040852 Aug 1999 WO
WO1999042059 Aug 1999 WO
WO1999055239 Nov 1999 WO
WO2000012031 Mar 2000 WO
WO2000021443 Apr 2000 WO
WO2000053105 Sep 2000 WO
WO2000072781 Dec 2000 WO
WO 2001021244 Mar 2001 WO
WO2001058366 Aug 2001 WO
WO2002032326 Apr 2002 WO
WO2003094751 Nov 2003 WO
WO2005035020 Apr 2005 WO
WO2005077281 Aug 2005 WO
WO2005113035 Dec 2005 WO
WO2006024040 Mar 2006 WO
WO2006047748 May 2006 WO
WO2006069123 Jun 2006 WO
WO2006081448 Aug 2006 WO
WO2006104881 Oct 2006 WO
WO2006114325 Nov 2006 WO
WO2006130743 Dec 2006 WO
WO2007041407 Apr 2007 WO
WO2007053568 May 2007 WO
WO2007070788 Jun 2007 WO
WO2007070792 Jun 2007 WO
WO2007070793 Jun 2007 WO
WO2007070797 Jun 2007 WO
WO2007118015 Oct 2007 WO
WO2007121405 Oct 2007 WO
WO2007123657 Nov 2007 WO
WO 2007124289 Nov 2007 WO
WO2008064205 May 2008 WO
WO2008064206 May 2008 WO
WO2008064209 May 2008 WO
WO2008066923 Jun 2008 WO
WO2008085606 Jul 2008 WO
WO2008109394 Sep 2008 WO
WO2008115544 Sep 2008 WO
WO2009012057 Jan 2009 WO
WO2009014883 Jan 2009 WO
WO2009073398 Jun 2009 WO
WO2009082716 Jul 2009 WO
WO2009086214 Jul 2009 WO
WO2009088969 Jul 2009 WO
WO2009154844 Dec 2009 WO
WO2010030348 Mar 2010 WO
WO2010045079 Apr 2010 WO
WO2010104955 Sep 2010 WO
WO2010117883 Oct 2010 WO
WO2010120653 Oct 2010 WO
WO2010120694 Oct 2010 WO
WO2010121037 Oct 2010 WO
WO2010121049 Oct 2010 WO
Non-Patent Literature Citations (24)
Entry
United States Patent and Trademark Office, Notice of Allowance dated Sep. 28, 2015 in U.S. Appl. No. 12/340,546, 9 pages.
United States Patent and Trademark Office, Final Office Action dated Oct. 9, 2014 in U.S. Appl. No. 12/340,546, 8 pages.
United States Patent and Trademark Office, Final Office Action dated Jun. 9, 2014 in U.S. Appl. No. 12/340,546, 6 pages.
United States Patent and Trademark Office, Office Action dated Dec. 6, 2013 in U.S. Appl. No. 12/340,546, 7 pages.
United States Patent and Trademark Office, Final Office Action dated Aug. 15, 2012 in U.S. Appl. No. 12/340,546, 9 pages.
United States Patent and Trademark Office, Notice of Allowance dated Feb. 15, 2012 in U.S. Appl. No. 12/340,616, 17 pages.
United States Patent and Trademark Office, Office Action dated Jan. 23, 2012 in U.S. Appl. No. 12/340,546, 6 pages.
United States Patent and Trademark Office, Final Office Action dated Oct. 26, 2011 in U.S. Appl. No. 12/340,616, 13 pages.
United States Patent and Trademark Office, Office Action dated Apr. 12, 2011 in U.S. Appl. No. 12/340,616, 13 pages.
United States Patent and Trademark Office, Office Action dated Sep. 3, 2010 in U.S. Appl. No. 12/340,616, 14 pages.
WIPO, U.S. International Search Authority, International Search Report dated Mar. 19, 2009 in International Patent Application No. PCT/US2008/087855, 2 pages.
PCT International Search Report and Written Opinion for International Patent Application No. PCT/US2008/071325, dated Oct. 20, 2008, 10 pages, ISA/US, Alexandria, Virginia.
United States Patent and Trademark Office, Office Action dated Nov. 20, 2008 in U.S. Appl. No. 12/275,126, 11 pages.
Canadian Intellectual Property Office, Notice of Allowance dated Nov. 28, 2007 in Canadian Patent Application No. CA2425544, 1 page.
Canadian Intellectual Property Office, Examiner's Report dated Feb. 19, 2007 in Canadian Patent Application No. CA2425544, 2 pages.
Canadian Intellectual Property Office, Examiner's Report dated Sep. 29, 2005 in Canadian Patent Application No. CA2325544, 4 pages.
IP Australia, Examination Report dated Jun. 27, 2005 in Australian Patent Application No. AU2002214623, 3 pages.
United States Patent and Trademark Office, Notice of Allowance dated Oct. 2, 2003 in U.S. Appl. No. 10/143,724, 11 pages.
WIPO, U.S. International Search Authority, International Search Report dated May 28, 2002 in International Patent Application No. PCT/US2001/032588, 5 pages.
Graves, V.B. et al., “Endovascular Occlusion of the Carotid or Vertebral Artery with Temporary Proximal Flow Arrest and Microcoils: Clinical Results,” AJNR Am J Neuroradiol, vol. 18, American Society of Neuroradiology, Aug. 1997, 6 pages.
Schmutz, F. et al., “Embolization of Cerebral Arteriovenous Malformations with Silk: Histopathologic Changes and Hemorrhagic Complications,” AJNR Am J Neuroradiol, vol. 18, American Society of Neuroradiology, Aug. 1997, 5 pages.
Rosenthal M.D., D. et al., “Endovascular infrainguinal in situ saphenous vein bypass: A multicenter preliminary report,” J. Vasc Surg Sep. 1992, vol. 3, No. 16, pp. 453-458, 6 pages.
Rosenthal, D. et al., “Angioscope-assisted endovascular occlusion of venous tributaries: preclinical studies,” Cardiovasc Surg Jun. 1993, vol. 1, No. 3, pp. 225-227, 3 pages.
Vinuela M.D., F. et al., “Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients,” J.Neurosung, vol. 86, Mar. 1997, 8 pages.
Related Publications (1)
Number Date Country
20160100819 A1 Apr 2016 US
Provisional Applications (1)
Number Date Country
61016154 Dec 2007 US
Divisions (1)
Number Date Country
Parent 12340546 Dec 2008 US
Child 14975224 US